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Abstract
Purpose of Review The olive tree (Olea europaea L.) has featured as a significant part of medicinal history, used to treat a variety
of ailments within folk medicine. TheMediterranean diet, which is rich in olive products, is testament toOlea europaeas positive
effects on health, associated with reduced incidences of cancer and cardiovascular disease. This review aims to summarise the
current literature regarding the therapeutic potential of Olea europaea products in cancer, detailing the possible compounds
responsible for its chemotherapeutic effects.
Recent Findings Much of the existing research has focused on the use of cell culture models of disease, demonstrating Olea
europaea extracts, and specific compounds within these extracts, have efficacy in a range of in vitro and in vivo cancer models.
The source of Olea europaeas cytotoxicity is yet to be fully defined; however, compounds such as oleuropein and verbascoside
have independent cytotoxic effects on animal models of cancer.
Summary Initial results from animal models are promising but need to be translated to a clinical setting. Treatments utilising
these compounds are likely to be well tolerated and represent a promising direction for future research.
Keywords Olive .Olea europaea . Chemotherapeutic . Cancer
Introduction
The olive tree (Olea europaea L.) and its products have been
an important commodity throughout human history. Today,
98% of olive products are cultivated in the Mediterranean
basin and are an important part of the economy of the region
[1]. The value of the olive tree, however, extends past eco-
nomics to its nutritional and medicinal properties [2]. Olive
tree products were used in traditional medicines to treat a
variety of ailments such as fever [3, 4]. In more recent times
however, it has demonstrated possibilities in cancer preven-
tion. Cancer rates in the Mediterranean are notably lower than
other western countries, with cancer rates in Greece of 279.8
per 100,000 compared to 352.2 and 319.2 in the USA and UK
respectively. It is expected that this protection is a result of
dietary differences between these populations, as the
Mediterranean diet is consistently associated with reduced in-
cidences of cancer and cardiovascular disease [5, 6].
Academic studies of the beneficial properties of olives ini-
tiated in 1854 with the work of Daniel Hanbury, who noted
that a decoction of olive leaf was effective in reducing fevers
associated with malaria [4, 7]. Many pharmacological reports
have since exhibited the potential of olive-based extracts to
relieve arrhythmia, increase blood flow, lower blood pressure,
inhibit viral activity and prevent intestinal muscle spasms [8,
9]. Scientific studies looking at the anti-proliferative compo-
nents of certain flora, have recently demonstrated this poten-
tial withinOlea europaea products, largely from in vitro stud-
ies using extracts in addition to testing isolated compounds
fromOlea europaea products [7]. This review will summarise
the key studies that relate to Olea europaea extract’s anti-
cancer effects and discuss compounds chosen for their high
abundance within Olea europaea, revealing their anti-
proliferation properties.
Olea europaea Extracts
The preponderance of research in this field has focussed on
the use of cell culture models of disease, with efficacy in a
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range of these cancer models. Fares et al. [10] studied the
effect of olive leaf extract (OLE) on human lymphoblastic
leukaemia cell line, Jurkat. The results reported a 78% inhibi-
tion of Jurkat cell proliferation at a concentration of 4 μg/mL
at 48 hours. However, the study could not elucidate the mech-
anism of apoptosis. OLE has demonstrated efficacy against
the myelogenous leukaemic cell line, K562. After a 72-h treat-
ment with 150 μg/mL of OLE, the cell proliferation was
inhibited to 17%, whilst also demonstrating a significant de-
crease in viability [11].
Examination of OLE on a pancreatic cancer cell line
(MiaPACa-2) demonstrated efficacy in culture [12]. At con-
centrations of 200 μg/mL, the OLE was able to reduce cell
viability to less than 1% compared with controls. Coccia et al.
[13] observed the cytotoxic effect of extra virgin olive oil
extract on two different bladder cancer cell lines. It was dem-
onstrated that oil significantly decreased proliferation in T24
and 5637 bladder cell lines in a dose dependent manner. Cell
viability of T24 cells was decreased by up to 90% with 100
μg/mL oil, with an IC50 of ~32 μg/mL, with similar treatment
efficacy in 5637 cells [13]. Furthermore, the cell cycle pro-
gression was monitored by flow cytometry, that observed a
growth arrest at the G2/M phase after treatment in both cell
lines. In the T24 cell line, a decrease was observed in the G0/
G1 phase and an increase in the sub-G1 fraction, indicative of
induction of apoptosis. Western blot analysis of pro-caspase-
3, -9 and PARP-1 further demonstrated an apoptotic effect of
oil [13]. Olive oil production generates waste materials often
referred to as olive mill wastewater. This wastewater still con-
tains many of the same compounds present in olives.
Recently, Baci et al. [14•] tested this wastewater on PC-3
prostate cancer cells in culture. The results demonstrated
wastewater was able to inhibit cell proliferation, adhesion,
migration and invasion. At a molecular level, the wastewater
was observed to inhibit NF-κB signalling in addition to reduc-
ing pro-angiogenic growth factors, VEGF, CXCL-8 and
CXCL-12 production. The results demonstrated that even
from the lowest dilution tested (1:5000), wastewater was able
to inhibit PC-3 cell proliferation [14•].
Isleem et al. [15] demonstrated the importance of extraction
techniques on OLE efficacy. In this study, OLE was mixed
with either deionised water or 80% methanol, and these ex-
tracts were subsequently tested individually in a dose- and
time-dependent manner on the human breast cancer cell line
MCF-7. After a 48-h treatment, the deionised water extract
had an IC50 value of 182 μg/mL whilst the methanol extract
was 135 μg/mL, versus relevant controls. Furthermore, the
source of the products are often not comparable, something
which is supported by in vivo studies. For example, a study by
Escrich, Moral and Solana [16] investigated how diets rich in
extra virgin olive oil reduce the risk of breast cancer compared
with diets high in corn oil. Olive oil induced molecular chang-
es in tumours that resulted in higher rates of apoptosis, lower
proliferation and lower DNA damage. Furthermore,
Milanizadeh and Reza Bigdeli [17] demonstrated a reduction
in mammary cancer weight and volume after a treatment of
150 and 225 mg/kg/day of OLE in a breast cancer mouse
model. This reduced growth was proposed to be related to
the polyphenol content of OLE, resulting in an increase of
antioxidant enzyme activity including superoxide dismutase
and catalase. The mechanisms responsible for inhibited tu-
mour growth are likely to stem from OLE polyphenols
blocking the cell cycle in G1/S through reducing COX2 and
cyclin D1 expression, which results in the reduction of cell
growth and proliferation [17, 18].
Whilst the source of cytotoxicity of OLE has yet to be fully
defined, oleuropein is the most abundant compound in olive
leaves, followed by hydroxytyrosol, luteolin, apigenin and
verbascoside. Oleuropein is a heterosidic ester of elenolic acid
and dihydroxyphenylethanol. Hydroxytyrosol (3,4-
Dihydroxyphenyl ethanol), is the principal degradation prod-
uct of oleuropein [19]. Within unprocessed olive fruit and
leaves, oleuropein is more abundant, whereas hydroxytyrosol
is present in higher amounts of processed olive fruit and leaves
[20]. This change in concentration takes place due to chemical
and enzymatic reaction that occurs during maturation of olive
products or as a result of processing. One key component of
olives and olive oil is their fatty acid composition. Olive oil
largely consists of triacylglycerols (98-99%), a group of glyc-
erol esters with varying fatty acids [21]. The main fatty acid in
olive oil is oleic acid; however, it also contains linoleic acid,
palmitic acid, palmitoleic acid, stearic acid and the triterpene
maslinic acid. A variety of amphiphilic and lipophilic
microconstituents exist in olive oil including, tocopherols,
squalene, phytosterols, and phenolic compounds [22]. These
compounds are summarised in Table 1.
Polyphenols
Polyphenols are a family of micronutrients, named due to the
presence of multiple hydroxylated phenol rings in their struc-
ture. These compounds are broadly water soluble and include
plant pigments and tannins [23]. The proposedmechanisms of
action associated with polyphenols are largely related to their
antioxidant activity, directly leading to a reduction in reactive
oxygen species (ROS) [24, 25]. Phenols, oleuroepsides and
flavonoids have proven to demonstrate significant antioxidant
activity towards free radicals, because of the redox properties
of their phenolic hydroxyl groups and the structural relation-
ships within their chemical structure [9]. Other research has
demonstrated the ability of polyphenols to modulate the hu-
man immune system, resulting in increased regulatory T cell
and splenocyte production, in addition to reducing oxidative
burst activity of neutrophils [26].
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Table 1 Phytochemicals isolated from Olea europaea (Olive tree) products
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C20H24O9 Olive oil [93]
10-
hydroxyoleuropein






























Comselogoside  C25H28O14 Olives [100]









C10H14O4 Olive oil [102]







Elenolic acid methyl 
ester
C12H16O6 Olive leaf [103]
Hydroxytyrosol-
elenolate
C18H20O8 Olive leaf [8]
Olive oil [104]
Ligstroside C25H32O12 Olives [99]
Olive leaf [8]
Olive oil [105]





Lucidumoside C C27H36O14 Olive leaf [107]
Oleocanthal C17H20O5 Olive oil [105]




Oleuropein C25H32O13 Olives [101]
Olive leaf [8,107]
Olive oil [105]




C31H42O18 Olive leaf [8]




Compound Formula Structure Product
Oleacein C17H20O6 Olive leaf [99]
Olive oil [105]
Oleuricine A C31H42O18 Olive leaf [110]
Curr Nutr Rep
Table 1 (continued)
Oleuricine B C31H42O18 Olive leaf [110]
Oleuroside C25H32O13 Olive leaf [8,107]
Flavonoids 
Compound Formula Structure Product

































Quercitrin C21H20O11 Olives [100]
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Table 1 (continued)




Compound Formula Structure Product
Apigenin-7-O-
glucoside
C21H13O11 Olive leaf [8,107]
Diosmetin C16H12O6 Olive leaf [112]
Luteolin-7,4 -O-
diglucoside 
C27H30O16 Olive leaf [112]
Phenolic compounds







7-deoxyloganic acid C16H24O9 Olives [97]
Cinnamic acid C9H8O2 Olives [97]
Olive leaf [8]
Ferulic acid C10H10O4 Olives [97]
Olive leaf [113]
Gallic acid C7H6O5 Olives [97]
Olive leaf [114]
Homovanillyl alcohol C9H12O3 Olive leaf
Olive oil [115,116]






C10H12O4 Olive leaf [8,107]
Olive oil [93]




Loganin C17H26O10 Olives [97]
Olive leaf [118]
p-coumaric acid C9H8O3 Olive leaf [8]
Olive oil [119]
Protocatechuic acid C7H6O4 Olives [97]
Olive leaf [113]
Quinic acid C7H12O6 Olive leaf [107]
Rosmarinic acid C18H16O8 Olives [97]
Secologanin C17H24O10 Olives [97], 
Olive leaf [118]
Shikimic acid C7H10O5 Olives [97]
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Table 1 (continued)
Taxifolin C15H12O7 Olives [97]
Tyrosol C8H10O2 Olives [120]
Olive leaf [8,121]
Olive oil [122]
Tyrosol acetate C12H1404 Olive oil [122]
Uvaol C30H50O2 Olives [120]
Olive leaf [123]
Vanillic acid C8H8O4 Olive leaf
[107,114]
Olive oil [124]
Vanillin C8H8O3 Olive leaf
[8,107,125]
Olive oil [124]
Verbascoside C29H36O15 Olives [117]
Olive leaf [8,107]
Triterpene alcohols






Citrostadienol C30H50O Olives [126]
Cycloartenol  C30H50O Olives [126]
Cycloeucalenol C30H50O Olives [126]
Erythrodiol C30H50O2 Olives [127]
Olive leaf [120]
Gramisterol C29H48O Olives [126]
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Table 1 (continued)
Obtusifoliol  C30H50O 
 
Olives [126] 
Taraxerol   C30H50O 
 
Olives [126] 
                           Triterpenoids   
 
Compound Formula Structure Product 
Betulinic acid C30H48O3 
 
Olives [128] 
Olive leaf [103] 




Olive leaf [123] 
Oleanolic acid C30H48O3 
 







Olive leaf [130] 
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Ursolic acid C30H48O3 
 
Olives [128] 
Olive leaf [8] 
-amyrin  C30H50O 
 
Olive leaf [131] 
-sitosterol C29H50O 
 
Olive leaf [132] 





Compound Formula Structure Product 
- tocopherols   C29H50O2 
 
Olives [133] 
Olive oil [134] 
- tocopherols   C28H48O2 
 
Olives [133] 
Olive oil [134] 
- tocopherols   C28H48O2 
 
Olives [133] 
Olive oil [134] 
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Table 1 (continued)
Lignan   
Compound Formula Structure Product 
1-acetoxypinoresinol C22H24O8 
 
Olive oil [116] 
1,5-anhydroxylitol   C5H10O4 
 

















Olive leaf [137] 
Pinoresinol C20H22O6 
 
Olive oil [116] 
Syringaresinol C22H26O8 
 
Olive leaf [8] 
Ischromans  











C15H14O3 Olive oil [139]
Fatty acids
Compound Formula Structure Product
Linoleic acid C18H32O2 Olive leaf [140]
Olive oil [141]
Linolenic acid C18H30O2 Olive leaf [140]
Olive oil [141]
Myristic acid C14H28O2 Olive leaf [140]
Olive oil [142]
Oleic acid C18H34O2 Olive leaf [140]
Olive oil [142]
Palmitic acid C16H32O2 Olive leaf [140]
Olive oil [142]
Palmitoleic acid C16H30O2 Olive leaf [140]
Olive oil [142]
Stearic acid C18H36O2 Olive leaf [140]
Olive oil [142]
Other acids















The concentration of polyphenols in olive products
can depend on factors including climate, cultivation,
maturity, rootstock, agricultural practices and the meth-
od of extraction, separation and quantification [27–29].
It was observed by Wang and Fordham [30] that the
phenolic content of olives is season dependent, with
olives harvested in the autumn having a higher polyphe-
nol and carotenoid content, and therefore, a higher an-
tioxidant capacity. Pereira [31] highlighted that black
olives present a higher antioxidant capacity than their
green counterpart, due to higher concentrations of phe-
nolic compounds in black olives. Thus, the different
variety of olives and processing result in polyphenol
content varying significantly in different olives and con-
sequently olive oil. Research studying the olive leaves
has observed notable variety and quantity of polyphe-
nols compared with olive oil, notably oleuropein and
hydroxytyrosol [32]. Just as with olives, the chemical
composition of olive leaves changes under conditions
such as climate, country of origin, moisture, storage
condition and soil content [33].
The reduced cancer rates associated with the Mediterranean
diet and the history of Olea europaea products in traditional
medicine have made olive tree products the focus of phytochem-
ical research [34–36]. Studies have identified some compounds
from olive tree products for a deeper investigation of their cyto-
toxic effect. The most ubiquitous compounds are the phenolic
compounds, flavonoids, secoiridoids and secoiridoid glycosides.
However, compounds such as flavanones, flavone glycosides,
triterpenes, benzoic acid derivatives, biophenols, sterols, sugars,
xylitol and isochromans have clear biological activities [28].
Secoiridoids
Secoiridoids are uniquely present in plants of Olearaceae fam-
ily [37]. Secoiridoids are monoterpenoids based on the 7,8-
secocyclopenta[c]-pyranoid skeleton. In plants, it is possible
that they derive from iridoids that are cleaved with redox
enzymes and subsequently undergo several secondary modi-
fications (oxidation, epoxidation, esterification) of the gener-
ated hydroxyl groups within the main skeleton. This produces
a group of compounds, which constitute the class [38].
OleuropeinOleuropein is recognised to have antiviral, antimi-
crobial and antifungal properties [39]. Moreover, oleuropein
has noted hypoglycaemic and hypotensive properties, and is a
powerful antioxidant [40, 41]. Oleuropein has proven to exert
protective properties against cancer and heart disease, in ad-
dition to supporting immunoregulatory actions [42].
Oleuropein inhibits migration and proliferation of human tu-
mour cells in culture. Hamadi and Castellon [43] demonstrat-
ed that oleuropein irreversibly rounds cancer cells, preventing
motility, replication and invasiveness, whilst these effects
were reversible upon treatment removal in normal cells. The
study [43] demonstrated this reversibility through carrying out
additional washing tests on Matrigel-free cultures of RPMI-
7951 melanoma cells in addition to normal cells. After 48 h of
extensive washing, normal cells flattened out and again be-
came mobile, whilst cancer cells remained immobilized. This
work was supported in vivo, when 1% oleuropein was admin-
istered to mice orally within drinking water leading to tumour
regression in 9-12 days [43]. The cell rounding triggered by
oleuropein is linked to the disruption of the actin cytoskeleton
Table 1 (continued)
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and actin filaments. In Hamadi and Castellon’s [43] study, it
was established that this effect was somewhat offset by the
addition of glucose in the culture media. Due to oleuropeins
glucose moiety, it is likely that oleuropein enters the cell
through glucose transporters (GLUTs). Removing
oleuropeins glucose moiety with β-glucosidase decreases its
anti-proliferative activity, demonstrating that entry of
oleuropein into the cell is at least partially dependent on the
glucose moiety [43]. Human malignancies are associated with
elevated glucose uptake and enhanced expression of several
GLUT isoforms [44]. This explains how normal cells can
reverse the rounding effects of oleuropein treatment, as nor-
mal cells have low expression of GLUTs [45, 46].
Numerous studies have demonstrated oleuropeins efficacy
against certain breast cancer cell lines. Sirianni et al. [47]
demonstrated the inhibition of estradiol-dependent activation
of extracellular regulated kinase 1/2 (ERK 1/2) by oleuropein
in the MCF-7 cell line. This is significant as estradiol stimu-
lates the growth of several breast tumours, through induced
cellular proliferation. It is established that oleuropein can re-
duce cell proliferation of MCF-7 and T47D cells, this reduce
proliferation is associated with the activation of autophagy
and suppression of migration and invasion; this is achieved
through p62 downregulation, in addition to Beclin-1 and
LC3II/LC3I upregulation [48]. Oleuropein increases the level
of ROS and induces apoptosis via modulating NF-κB activa-
tion cascade, within MDA-MB-231 and MCF-7 cell lines
[49]. Elamin et al. [50], treated breast cancer xenografts (in
nude mice) in vivo, with a combination of doxorubicin and
oleuropein. This treatment combination resulted in a down-
regulation of NF-κB, Bcl-2 and survivin, triggering apoptosis.
All treatments significantly reduced tumour volume compared
to untreated controls (tumour volume, 173mm3). However,
combination therapy of doxorubicin and oleuropein
(48.7mm3) had greater efficacy than either doxorubicin
(69mm3) or oleuropein (79mm3) alone. Oleuropein has further
demonstrated efficacy in numerous cancer cell lines such as
colorectal, thyroid and lung [51–54]. Future work will be
needed to apply this research to the clinical environment.
Oleocanthal Studies have outlined the potential of oleocanthal
for cancer prevention in many cancer types. Akl et al. [55]
demonstrated that oleocanthal can inhibit the growth of hu-
man breast cancer cell lines MCF-7, MDA-MB-231 and BT-
474, whilst not affecting normal human cell growth of
MCF10A. Possible mechanisms of action in these cell lines
point to the blocking of cell migration, invasion and G1/S cell
cycle progression. This mechanism occurs through the inhibi-
tion of Hepatocyte growth factor (HGF)-induced c-Met acti-
vation [55]. Oleocanthal was investigated for its
antiproliferation activity in human melanoma cell lines,
501Mel and A375. It was determined that oleocanthal inhibits
cyclooxygenase enzymes to exert important anti-
inflammatory activities [56]. This study demonstrated that
oleocanthal did not produce significant changes in human
dermal fibroblast viability, signifying selective activity for
cancer cells over normal cells. This selectivity has been asso-
ciated with oleocanthals ability to induce lysosomal mem-
brane permeabilization leading to apoptosis and/or necrosis.
Cancer cells largely have weak lysosomal membranes com-
pared to noncancerous cells, thus making them susceptible to
cell death via lysosomotropic agents [57]. Fogli et al. [56]
demonstrated oleocanthal induced cell growth inhibition in
501Mel and A375 cells in a concentration-dependent manner,
with an IC50 of 13.6 and 20 μM respectively. It was demon-
strated that oleocanthal downregulates Bcl-2, Erk1/2 and
AKT signal transduction pathways [56, 58]. These pathways
play a key role in oleocanthal-induced cytotoxicity in multiple
myeloma cells. Moreover, the activation of the AKT pathway
is closely associated with resistance to BRAF inhibitors in
melanoma patients [59].
Flavonoids
Flavonoids are secondary metabolites corresponding to poly-
phenols that have a diverse structure, taking the form glyco-
sides or aglycones in fruits and vegetables such as onions,
berries, kale, and green tea [60]. Flavonoids have a chemical
structure of 15 carbons, with a skeleton of phenyl-benzo-γ-
pyran (C6–C3–C6), also known as nucleus flava, composed
of two phenyl rings and a heterocyclic (pyran) ring.
Flavonoids comprise of flavones, flavonols, flavonoids, flava-
nones, isoflavones and anthocyanidins [61].
Apigenin A recent study investigated the anti-proliferative ef-
fects of apigenin, an abundant flavonoid, on the human cervi-
cal cancer cell line HeLa [62]. Initial research demonstrated an
IC50 of 15 μM – similar to that observed for some common
chemotherapeutics. Reduced viability was associated with an
apoptotic profile as determined by annexin V and propidium
iodide positivity. This was demonstrated by Western blot
where apigenin increased the expression of Bax and decreased
the expression of Bcl-2, commonly observed in apoptosis.
The authors concluded that apigenin has apparent potential
as a chemotherapeutic agent [62]. Erdogan et al. [63] observed
apigenin reduce prostate cancer stem cell survival and migra-
tion, via treating PC3 and cancer stem cells with a series of
μM concentrations of apigenin for 48 hours. In a dose-
dependent manner, apigenin inhibited PC3 and cancer stem
cell survival, that was associated with PI3K, AKT and NF-κB
downregulation, and increases in p27 and p21. Apigenin sig-
nificantly suppressed themigration rate of CD44+ cancer stem
cells, as determined by a wound healing assay. This supressed
migration was through downregulation of matrix
metallopeptidases-2, -9, Snail and Slug. Thus, Erdogan et al.
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[63] highlighted apigenin to potentially prevent the prolifera-
tion and migration of cancer cells. Xu et al. [64] demonstrated
apigenin to suppress colorectal cancer cell proliferation, mi-
gration and invasion through the inhibition of the Wnt/β-
catenin signalling pathway. The occurrence of human tumor-
igenesis can be significantly affected by abnormal activation
of the Wnt/β-catenin signalling pathway. Xu et al. [64] dem-
onstrated antiproliferation effects of apigenin on HCT15 and
SW480 colorectal cancer cell lines in vitro. It was determined
that apigenin significantly reduced HCT15 and SW480 cell
proliferation at an IC50 of 23.57 μM and 18.17 μM,
respectively.
Luteolin-7-O-glucoside Maatouk et al. [65••] investigated the
protective role of luteolin-7-O-glucoside on oxidative stress in
addition to DNA damage induced by cisplatin through comet
assay. Balb/c mice were injected with 10 mg/kg of cisplatin
following luteolin-7-O-glucoside treatment (40 mg/kg). The
results demonstrated that luteolin-7-O-glucoside attenuates
the genotoxicity associatedwith cisplatin [65••]. This included
a reduction in markers of tissue damage (creatinine, interferon
γ) and oxidative stress (malondialdehyde, catalase, glutathi-
one peroxidase, superoxide dismutase, and glutathione).
Work on the liver cancer cell line HepG2 demonstrated that
exposure to luteolin 7-glucoside and apigenin 7-glucoside re-
duced cell viability, with an IC50 of 21 μg/mL and 17 μg/mL,
respectively. These compounds reduced the expression of
NF-κB, a key pathway in the chronic inflammation associated
with hepatocellular carcinoma [66].
Hydroxytyrosol Hydroxytyrosol was revealed to possess anti-
bacterial, antioxidative, and anti-inflammatory properties [51].
Evidence further demonstrated effective chemotherapeutic
properties through affecting several signalling pathways [67];
notably growth factor receptors [52, 68, 69], receptor support
proteins [70, 71] and interleukin pathways [72]. Inhibition of
cyclin D1 is core to hydroxytyrosol efficacy, resulting in cell
cycle arrest at G1/S phase in the MCF-7 cell line [7]. Several
studies have referenced cyclin D1 downregulation following
hydroxytyrosol treatment in many cancer cell lines, including
breast cancer (MCF-7, MB231) [7, 71], colon cancer (Caco-2)
[73], and thyroid cancer (TPC-1, FB-2, WRO) [74].
Furthermore, hydroxytyrosol has exhibited protection
to peripheral blood mononuclear cells from hydrogen
peroxide-induced DNA damage and prevention of endo-
plasmic reticulum stress in hepatocellular carcinoma
Hep G2 [75, 76]. Conversely, hydroxytyrosol has dem-
onstrated ROS production, leading to apoptotic cell
death and mitochondrial dysfunction in DLD1 colon
cancer cells [77]. Moreover, evidence suggests that
hydroxytyrosol can cause superoxide and hydrogen per-
oxide generation leading to induction of apoptosis in
prostate cancer PC3 cells [78].
Zubair et al. [79] tested hydroxytyrosol on normal
prostate epithelial cells (PWLE2 and RWPE1) alongside
cancerous cells (LNCaP and C4-2), demonstrating inhi-
bition of proliferation in a dose-dependent manner. The
study revealed hydroxytyrosol inhibited cyclins D1/E
and cyclin-dependent kinases cdk2/4 and induced the
cell cycle inhibitors p21/p27, resulting in G1/S cell cy-
cle arrest [79]. Hydroxytyrosol induced apoptosis, as
demonstrated through caspase activation, PARP cleav-
age, and BAX/Bcl-2 ratio. Phosphorylation of Akt/
STAT3 was inhibited and cytoplasmic retention of NF-
kB was induced, which relates to the induction of apo-
ptosis. Prostate cancers usually retain androgen receptor
signalling and are normally dependent on activated Akt,
NF-kB, and STAT3 signalling [80–82]. Hydroxytyrosol
exhibits a pleiotropic activity against these signalling
pathways leading to cell cycle arrest [79]. Terzuoli et al.
[69] demonstrated that hydroxytyrosol significantly
downregulates epidermal growth factor receptor expres-
sion in human colorectal adenocarcinoma cells (HT-29,
WiDr and CaCo2). They concluded that hydroxytyrosol
downregulated receptor expression through proteasomal
and lysosomal degradation via receptor ubiquitination.
This led Terzuoli et al. [69] to highlight the potential
of hydroxytyrosol as a novel colon tumour treatment.
Verbascoside Verbascoside has demonstrated anti-tumour
effects in some human cancers. Apoptosis promotion by
verbascoside is associated with HIPK2, p53, HIF-1α
and Rac-1 in colorectal cancer cell lines [83, 84], in
addition to downregulation of STAT3, epithelial-to-
mesenchymal transition (EMT) markers (vimentin, snail
and zeb1) and c-Met in glioblastomas [85, 86]. Hei
et al. [85] further demonstrated the downregulation of
the EMT markers and c-Met in an orthotopic glioblas-
toma xenograft mouse model. EMT is a fundamental
hallmark of metastatic tumourigenesis and has an essen-
tial role in glioma aggressiveness [87]. Hei et al. [85]
highlighted that verbascoside can bind directly to the c-
Met protein, and that verbascoside causes c-Met protein
degradation through the ubiquitination-proteasome path-
way. Furthermore, verbascoside was able to suppress
tumour growth and enhance survival in mice [85].
This model demonstrated that verbascoside exerted ef-
fects via the same mechanisms in vivo as it did in vitro,
by suppressing c-Met-mediated EMT and inducing can-
cer death.
Triterpenoids
Triterpenoids are structurally varied organic compounds,
made of a basic backbone modified in a multitude of ways,
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creating the formation of over 20,000 naturally occurring
triterpenoids [88]. Triterpenoids are characterised by 30 car-
bon atoms, polymerised to form six isoprene units.
Biosynthesis of triterpenoids occurs when its precursor squa-
lene undergoes cyclization. Triterpenoids chemical structure
is grouped from linear, through to pentacyclic [89]. Maslinic
acid, oleanolic acid, erythrodiol and uvaol are the most abun-
dant triterpenes in olive tree products [90].
Maslinic and Oleanolic Acid Juan et al. [91] observed the effect
of maslinic and oleanolic acid (two triterpenoids with similar
structure) on HT-29 colon cancer cells. These compounds were
examined for their effect on proliferation, necrosis and apopto-
sis. Maslinic acid inhibited cell growth with an IC50 of 101.2
μM, whilst oleanolic acid demonstrated lesser antiproliferation
activity with an IC50 of 160.6 μM. Maslinic acid increased
caspase-3-like activity that was associated with increased pres-
ence ofmitochondrial ROS, whereas oleanolic acid cytotoxicity
was not associated with either activated caspase-3 or ROS pro-
duction [91]. Detection of increased DNA fragmentation and
increase in plasmamembrane permeability confirmed apoptosis
by maslinic acid. Kim et al. [92•] investigated oleanolic acid-
induced cancer cell death, apoptotic mechanisms, cell cycle
status, and MAPK kinase signalling in MCF-7, DU145 (pros-
tate cancer) and U87 (human glioblastoma) cell lines. The IC50
values for oleanolic acid-induced cytotoxicity were 132.29 in
MCF-7, 112.57 in DU145 and 163.60 in U87 cells. At 100 μg/
mL oleanolic acid, there was an increased number of apoptotic
cells to 27.0% in MCF-7, 27.0% in DU145 and 15.7% in U87,
when compared to control cells [92•]. This greater apoptosis
was a result of increased p53, cytochrome c, Bax, PARP-1
and caspase-3 expression in the cell lines. Furthermore, the
different cancer lines arrested at varying phases of the cell cycle,
MCF-7 and U87 cells arrested in G1, whereas DU145 cells
arrested in G2 [92•]. This suggests that oleanolic acid alters
the expression of the cell cycle regulatory proteins inconsistent-
ly in different types of cancer cell lines.
Conclusion
Interest in Olea europaea products is increasingly researched
for their beneficial effect on human health. The polyphenols
detected in these products are of growing interest due to their
effect on ROS production. However, this is not their only
means of inhibiting cell proliferation in cancer. Natural plant
polyphenols have demonstrated the ability to alter the level of
ROS, either protecting biomolecules from oxidative damage
(e.g., luteolin-7-O-glucoside) or inducing oxidative damage
(e.g., maslinic acid). Oleuropein, hydroxytyrosol and
triterpenoids are abundant in Olea europaea products. These
polyphenolic compounds demonstrate powerful anti-oxidant,
anti-angiogenic, chemotherapeutic and anti-inflammatory
characteristics. Despite the continued positive results from
in vitro studies on the beneficial properties of Olive europaea
products, further in vivo investigation is needed. Initial results
in animal models are promising but need to be translated to
clinical setting. Treatments utilising these compounds are like-
ly to be well tolerated, as initial animal experimentation has
demonstrated [43, 50, 65, 85]. Nevertheless, initial investiga-
tion is encouraging in relation to the prevention and treatment
of cancer.
Abbreviations GLUT, glucose transporters; IC50, half maximal inhibi-
tory concentration; OLE, olive leaf extract; PARP, poly-ADP ribose po-
lymerase; ROS, reactive oxygen species
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